Atherosclerosis
Atherosclerosis evolves silently, driven by lipid burden and vascular inflammation. Biomarker testing clarifies arterial risk and system stress before symptoms. At Superpower, we test LDL, ApoB, Lp(a), hs-CRP, AIP, and AC to quantify particle load, inflammatory tone, and atherogenic balance—making plaque biology visible and trackable.
BPH
Biomarker testing clarifies prostate growth activity in BPH, signaling glandular enlargement and obstruction risk. PSA reflects total prostatic protein output; the free-to-total PSA ratio refines specificity, distinguishing benign hyperplasia from inflammation or cancer. At Superpower, we test PSA Total and Free PSA to map prostate physiology and monitor change.
Coronary Artery Disease
Biomarker testing clarifies your cardiovascular risk by showing how lipids and inflammation drive plaque formation. At Superpower, we measure LDL and HDL cholesterol, ApoB, Lp(a), hs-CRP, plus composite ratios NHR and AIP, to map atherosclerotic burden and endothelial stress underlying coronary artery disease.
Heart Failure
Biomarker testing clarifies heart failure’s impact across systems—fluid balance, kidney function, inflammation, and nutritional status. At Superpower, we test for Albumin, Sodium, Creatinine, and hs-CRP for Heart Failure to detect congestion, renal stress, systemic inflammation, and protein status (oncotic pressure), guiding earlier recognition and risk stratification.
Hypertension
Hypertension reflects disrupted fluid balance and vascular tone. Biomarker testing clarifies kidney–sodium handling and neurohormonal control (renin–angiotensin–aldosterone). At Superpower, we test Sodium and Potassium to assess electrolyte status influencing blood volume, arterial stiffness, and pressure regulation, linking everyday physiology to measurable drivers of elevated blood pressure.
Myocardial Infarction
Biomarker testing clarifies cardiovascular risk and tissue stress that drive myocardial infarction. It surfaces silent vascular inflammation and atherogenic burden before events. At Superpower, we measure hs-CRP and LDL/HDL markers to profile endothelial inflammation and lipid transport balance, revealing system-level vulnerability to plaque rupture and coronary thrombosis.
Obesity
Obesity is a systemic condition; biomarker testing clarifies the metabolic and inflammatory burden that drives weight gain and cardiometabolic risk. At Superpower, we measure Insulin, Glucose, Lipids, and hs-CRP to map insulin dynamics, glycemic status, atherogenic profile, and low-grade inflammation (insulin resistance, dyslipidemia).
Peripheral Artery Disease
Peripheral artery disease stems from atherosclerosis and vascular inflammation. Biomarkers quantify lipoprotein burden and inflammatory tone, revealing arterial injury risk early. At Superpower, we measure LDL, ApoB, Lp(a), hs-CRP, and AIP to map atherogenic risk and vascular stress, clarifying disease trajectory before symptoms.
Prediabetes
Biomarker testing reveals early glucose dysregulation, showing how your body processes sugar now and over months. At Superpower, we test Glucose and HbA1c for Prediabetes to profile glycemic control and insulin resistance, via fasting plasma glucose and hemoglobin A1c—quantifying chronic glucose exposure.
Stroke
Biomarker testing clarifies stroke risk by mapping vascular injury, atherosclerosis, and immune activity. Lipoprotein measures (LDL, HDL), particle burden (ApoB), and inherited lipoprotein(a) [Lp(a)] reflect plaque formation; inflammation markers (hs-CRP) and leukocyte ratios (NLR, MLR) reflect instability. At Superpower, we test for LDL, HDL, ApoB, Lp(a), hs-CRP, NLR, MLR.
Vitamin B12 Deficiency
Vitamin B12 powers red blood cell production and nervous system function. Testing detects early macrocytic anemia and functional deficits before symptoms escalate. At Superpower, we assess Hemoglobin, MCV, MCH, MCHC, RDW, Vitamin B12, and Folate to map erythropoiesis, cell size, and methylation pathways driving B12 status.
Vitamin D Deficiency
Vitamin D status shapes bone integrity, muscle function, and immune regulation. Biomarker testing identifies deficiency early and clarifies mineral balance. At Superpower, we test Vitamin D and Calcium for Vitamin D Deficiency, connecting hormone activity with serum calcium homeostasis to assess overall musculoskeletal and systemic health.
